Rethinking the Approach to Advancing Cannabinoid-Based Drug Development: A Case Study of Musculoskeletal Pain & Inflammation
Time: 9:00 am
day: Day One
Details:
- Optimizing cannabinoid-based formulations for topical application
- Challenges with current preclinical models and their translation to human experience
- Using AI and observational data to determine the preclinical pathway
